ERIS Lifesciences Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹490.49Cr |
Net Profits | ₹102.74Cr |
Net Profit Margins | 20.95% |
Highlights
Revenue:
ERIS Lifesciences Ltd’s revenue jumped 15.27% since last year same period to ₹490.49Cr in the Q3 2023-2024. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -3.59% fall in its revenue since last 3-months.
Net Profits:
ERIS Lifesciences Ltd’s net profit jumped 0.86% since last year same period to ₹102.74Cr in the Q3 2023-2024. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -16.76% fall in its net profits since last 3-months.
Net Profit Margins:
ERIS Lifesciences Ltd’s net profit margin fell -12.5% since last year same period to 20.95% in the Q3 2023-2024. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -13.66% fall in its net profit margins since last 3-months.
